Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation.

Erythropoiesis-stimulating agents (ESAs) are used in treating cancer- and chemotherapy-induced anemia with the aim of accelerating the recovery of red blood cells (RBCs), reduce the risks associated with RBC transfusions and improve quality of life.